what metrics actually matter when picking a treatment center for peritoneal meso

The volume question is real but the number that actually changed how I counsel patients is from the Sugarbaker data out of Washington Hospital Center, which showed morbidity rates dropping significantly once a program crossed roughly 130 cumulative cases, not just annual volume. So asking "how many have you done total" matters as much as the yearly number.

The previous hysterectomy piece you flagged is genuinely worth pressing on. Adhesions (scar tissue from prior surgery) complicate cytoreduction in ways that affect completeness of resection scores, and a CC-0 or CC-1 score at the end of surgery is honestly one of the strongest predictors of outcome in peritoneal meso. I'd ask them directly what their CC-0 rate is for patients with prior abdominal surgery specifically, not their overall rate.

One thing nobody usually thinks to ask... what's their protocol when they open and find more disease than imaging suggested. Because CT and MRI undersell peritoneal burden pretty consistently. How a team makes that intraoperative call tells you a lot about their judgment and whether they'll have a real conversation with you or just proceed.

Your instinct about the integrated team is good. At the best programs I've seen, the surgeon and the medical oncologist have been in the same room planning your case before you ever get on the table. Talk to your own oncologist about what that coordination actually looks like at any center you're considering, not just what their website says.

Your list is really solid, honestly better than what most people bring into this process. The question about previous abdominal surgery is one I wish more patients asked upfront because adhesions from a hysterectomy absolutely affect how complex the cytoreduction becomes, and some centers just don't engage with that honestly until you're already committed.

A few things I'd add from what I've seen over the years. Ask what percentage of their HIPEC cases they complete to optimal cytoreduction, meaning R0 or R1 resection. That number tells you more than annual volume alone. The Washington University program in St. Louis published data showing their completeness of cytoreduction rate was the single strongest predictor of survival in peritoneal cases, stronger even than stage at diagnosis. Talk to your own doctor about how to interpret those numbers for your specific situation.

The integrated team piece on your list matters more than people realize. I've sat with patients who had their surgical and chemo teams basically emailing each other, and it creates gaps in care that show up three months post-op.

One thing that's easy to overlook... ask about their patient navigator or care coordinator specifically for out-of-state patients. Some programs are extraordinary surgically and genuinely difficult logistically if you're not local. Six weeks post-diagnosis is a lot to manage without that support structure.

If you're finding the decision feels overwhelming on top of everything else, that's completely normal and worth talking to someone about. A lot of cancer centers have oncology social workers on staff who can help you sort through this, and if you find yourself stuck or anxious in a way that's not lifting, that's worth a dedicated session with someone who specializes in this.

Your list is already better than what most patients bring into these consultations, so that's genuinely reassuring to see.

The volume question is real. The data from Esquivel et al. in the Annals of Surgical Oncology is pretty consistent that centers doing fewer than 15 to 20 cases a year see meaningfully worse morbidity numbers, and for peritoneal meso specifically the learning curve is steep. But volume is a floor, not a ceiling. What I'd push harder on is the peritoneal cancer index (PCI) score they assigned you, and whether the surgeon can speak specifically to how your prior hysterectomy affects their expected completeness of cytoreduction (CC) score. A CC-0 or CC-1 resection is where survival benefit lives. If they hedge on that question before even seeing your imaging in person, that tells you something.

The integrated team piece matters more than people realize. When your surgical oncologist and your medical oncologist are in the same tumor board, having the same conversation before you ever hit the OR, the coordination just looks different. I saw this firsthand when a patient I was following transferred from a community program to a center where the teams were truly co-located and the whole treatment sequencing changed within two weeks of the transfer.

Ask them specifically what their 30-day and 90-day mortality rates are for epithelioid peritoneal cases. Good programs track this granularly and won't flinch at the question. If you get a vague answer, that's your answer.

Brigham has historically had very strong peritoneal numbers. MD Anderson is excellent. There are also programs at Wake Forest and the Siteman Cancer Center in St. Louis that do strong volume and are worth a call if geography or logistics become a factor.

Talk to your oncologist about all of this, because your specific PCI, your prior surgical history, and your overall performance status should be driving this decision as much as anything I can tell you here.

Your list is honestly really good, better than what most patients come in with. The volume threshold question is exactly right, the Sugarbaker data going back to the early 2000s showed that mortality rates dropped significantly once centers crossed that 20-case threshold, and some more recent registry analyses put the sweet spot closer to 30+ for peritoneal meso specifically.

A few things I'd add from what I've seen in practice. Ask them directly how they define "complete cytoreduction" and what percentage of their peritoneal meso cases achieve a CC-0 or CC-1 score (that's completeness of cytoreduction, basically how much residual tumor is left after surgery). That number correlates with survival more than almost anything else in the literature. A center that's vague about this or quotes you overall HIPEC numbers without breaking out meso from colorectal is a yellow flag.

The prior hysterectomy question is a smart one and you should push on it hard. Adhesions from a 1998 hysterectomy can complicate the peritoneal stripping significantly and a surgeon who's done 200 virgin-abdomen cases may have a different complication profile than one who's specifically comfortable with re-operative fields. Ask how many of their meso cases involved prior abdominal surgery.

One thing people don't always think to ask: who manages you if something goes wrong at 2am? Is there a dedicated HIPEC team covering nights or are you getting a general surgery resident who's never seen this before. I've seen that question catch programs off guard in ways that were pretty telling.

Brigham and MD Anderson are both legitimate referrals. Talk to your oncologist before making any final calls on this.

Your list is honestly really solid, and the fact that you're separating pleural from peritoneal outcomes in your questions puts you ahead of most people I've worked with at this stage.

The prior abdominal surgery question is one I wish more people asked upfront. I had a patient a few years back who disclosed her prior surgeries only at pre-op and it changed the surgical plan significantly. The good centers will want that history before they even quote you a timeline.

A few things I've seen matter that don't always show up on websites... ask specifically who runs the post-op nutrition protocol, because HIPEC recovery is heavily tied to how aggressively they manage that in the first two weeks. And ask whether the surgical oncologist and the medical oncologist have a standing tumor board or just "communicate." There's a real difference. Some programs feel genuinely integrated, others are just adjacent offices.

The Brigham program has published outcome data you can actually pull, so you can cross-reference what they tell you on the phone against their own literature. That's worth doing.

And because you mentioned the hysterectomy, epithelioid histology at Stage II actually has some of the more encouraging survival data in this population, so you're working with a relatively favorable picture here.

What I'd gently say is that if the anxiety around all of this is getting heavy, which is completely understandable six weeks out, talking to someone who specializes in oncology social work can help you think through decisions without the emotional static. Your care team may have someone on staff, and if the feelings persist, working with a licensed counselor who knows this space makes a real difference.